{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:26:48Z","timestamp":1762918008945,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Hellenic Rheumatology Association"},{"name":"CPM"},{"name":"a S. Niarchos Foundation Grant to Department of Physiology"},{"DOI":"10.13039\/501100005187","name":"National and Kapodistrian University of Athens, Athens, Greece","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HarmonicSS European Union Project","award":["731944"],"award-info":[{"award-number":["731944"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cyto.2019.154781","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T01:18:22Z","timestamp":1563412702000},"page":"154781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["TREX1 variants in Sjogren's syndrome related lymphomagenesis"],"prefix":"10.1016","volume":"132","author":[{"given":"Adrianos","family":"Nezos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Makri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saviana","family":"Gandolfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Voulgarelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Crow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clio P","family":"Mavragani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2019.154781_b0005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-pathol-012513-104728","article-title":"Sjogren's syndrome","volume":"9","author":"Mavragani","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"10.1016\/j.cyto.2019.154781_b0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.cyto.2019.154781_b0015","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cyto.2019.154781_b0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sjogren Syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"British J. Haematol."},{"issue":"2","key":"10.1016\/j.cyto.2019.154781_b0025","doi-asserted-by":"crossref","first-page":"e0116189","DOI":"10.1371\/journal.pone.0116189","article-title":"Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients","volume":"10","author":"Papageorgiou","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cyto.2019.154781_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-Hodgkin lymphoma in primary Sjogren syndrome","volume":"91","author":"Voulgarelis","year":"2012","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.cyto.2019.154781_b0035","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheumat."},{"issue":"20","key":"10.1016\/j.cyto.2019.154781_b0040","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.cyto.2019.154781_b0045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jaut.2012.05.011","article-title":"Endocrine alterations in primary Sjogren's syndrome: an overview","volume":"39","author":"Mavragani","year":"2012","journal-title":"J. Autoimmunity"},{"issue":"4","key":"10.1016\/j.cyto.2019.154781_b0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/gene.2009.20","article-title":"Peripheral blood gene expression profiling in Sjogren's syndrome","volume":"10","author":"Emamian","year":"2009","journal-title":"Genes. Immun."},{"issue":"12","key":"10.1016\/j.cyto.2019.154781_b0055","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/art.23062","article-title":"Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept","volume":"56","author":"Mavragani","year":"2007","journal-title":"Arthritis Rheumat."},{"key":"10.1016\/j.cyto.2019.154781_b0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","article-title":"Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis","volume":"63","author":"Nezos","year":"2015","journal-title":"J. Autoimmunity"},{"issue":"8","key":"10.1016\/j.cyto.2019.154781_b0065","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.4049\/jimmunol.1401334","article-title":"Phenotypic variation in Aicardi-Goutieres syndrome explained by cell-specific IFN-stimulated gene response and cytokine release","volume":"194","author":"Cuadrado","year":"2015","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.cyto.2019.154781_b0070","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.39795","article-title":"Expression of long interspersed nuclear element 1 retroelements and induction of Type I interferon in patients with systemic autoimmune disease","volume":"68","author":"Mavragani","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.cyto.2019.154781_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13100-016-0070-z","article-title":"Restricting retrotransposons: a review","volume":"7","author":"Goodier","year":"2016","journal-title":"Mob DNA"},{"key":"10.1016\/j.cyto.2019.154781_b0080","doi-asserted-by":"crossref","first-page":"754825","DOI":"10.1155\/2015\/754825","article-title":"Contribution of genetic factors to Sjogren's syndrome and Sjogren's syndrome related lymphomagenesis","volume":"2015","author":"Nezos","year":"2015","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.cyto.2019.154781_b0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.stem.2017.07.009","article-title":"Modeling of TREX1-dependent autoimmune disease using human stem cells highlights L1 Accumulation as a source of neuroinflammation","volume":"21","author":"Thomas","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.cyto.2019.154781_b0090","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/art.39231","article-title":"A BAFF receptor His159Tyr mutation in Sjogren's syndrome-related lymphoproliferation","volume":"67","author":"Papageorgiou","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2019.154781_b0095","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1038\/s41598-017-07347-w","article-title":"MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome","volume":"7","author":"Fragkioudaki","year":"2017","journal-title":"Sci. Rep."},{"issue":"28","key":"10.1016\/j.cyto.2019.154781_b0100","doi-asserted-by":"crossref","first-page":"19655","DOI":"10.1074\/jbc.274.28.19655","article-title":"Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3'\u2013>5' exonucleases","volume":"274","author":"Mazur","year":"1999","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.cyto.2019.154781_b0105","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1093\/emboj\/18.13.3868","article-title":"A human DNA editing enzyme homologous to the Escherichia coli DnaQ\/MutD protein","volume":"18","author":"Hoss","year":"1999","journal-title":"EMBO J."},{"issue":"Pt 3","key":"10.1016\/j.cyto.2019.154781_b0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/BST0370535","article-title":"Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease","volume":"37","author":"Lindahl","year":"2009","journal-title":"Biochem Soc Trans"},{"issue":"12","key":"10.1016\/j.cyto.2019.154781_b0115","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.4161\/cc.7.12.6162","article-title":"New roles for the major human 3'-5' exonuclease TREX1 in human disease","volume":"7","author":"Kavanagh","year":"2008","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.cyto.2019.154781_b0120","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/rheumatology\/ket372","article-title":"A nationwide survey of Aicardi-Goutieres syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study","volume":"53","author":"Abe","year":"2014","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.cyto.2019.154781_b0125","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ng1845","article-title":"Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus","volume":"38","author":"Crow","year":"2006","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.cyto.2019.154781_b0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10875-015-0147-3","article-title":"Human disease phenotypes associated with mutations in TREX1","volume":"35","author":"Rice","year":"2015","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2019.154781_b0135","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513443","article-title":"Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome","volume":"80","author":"Rice","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.cyto.2019.154781_b0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/jamadermatol.2014.3438","article-title":"Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1)","volume":"151","author":"Gunther","year":"2015","journal-title":"JAMA Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2019.154781_b0145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.cyto.2019.154781_b0150","doi-asserted-by":"crossref","first-page":"471703","DOI":"10.1155\/2013\/471703","article-title":"Rare variants in the TREX1 gene and susceptibility to autoimmune diseases","volume":"2013","author":"Barizzone","year":"2013","journal-title":"Biomed. Res. Int"},{"issue":"12","key":"10.1016\/j.cyto.2019.154781_b0155","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1002\/art.38824","article-title":"Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by Whole-exome sequencing","volume":"66","author":"Ellyard","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.cyto.2019.154781_b0160","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","article-title":"Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study","volume":"12","author":"Rice","year":"2013","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.cyto.2019.154781_b0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/03009742.2016.1195872","article-title":"A synonymous variant in TREX1 is associated with systemic sclerosis and severe digital ischaemia","volume":"46","author":"Hughes","year":"2017","journal-title":"Scand J. Rheumatol."},{"issue":"7","key":"10.1016\/j.cyto.2019.154781_b0170","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.cell.2015.11.054","article-title":"Chromothripsis and kataegis induced by telomere crisis","volume":"163","author":"Maciejowski","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2019.154781_b0175","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nature Commun."},{"issue":"10","key":"10.1016\/j.cyto.2019.154781_b0180","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sjogren's syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"New England J. Med."},{"issue":"1","key":"10.1016\/j.cyto.2019.154781_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1573395511309010003","article-title":"Possible mechanisms of lymphoma development in Sjogren's syndrome","volume":"9","author":"Dong","year":"2013","journal-title":"Current Immunol. Rev."},{"issue":"6","key":"10.1016\/j.cyto.2019.154781_b0190","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Study group on classification criteria for Sjogren's, classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheumat. Dis."},{"issue":"5","key":"10.1016\/j.cyto.2019.154781_b0195","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.21.5.656","article-title":"Labial salivary gland biopsy in Sjogren's disease","volume":"21","author":"Chisholm","year":"1968","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.cyto.2019.154781_b0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0030-4220(74)90160-1","article-title":"Minor salivary gland involvement in Sjogren's syndrome","volume":"37","author":"Tarpley","year":"1974","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.cyto.2019.154781_b0205","first-page":"519-23","article-title":"A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http:\/\/analysis.bio-x.cn)","volume":"19(4)","author":"Li","year":"2009","journal-title":"Cell Res."},{"issue":"15","key":"10.1016\/j.cyto.2019.154781_b0210","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: a web tool for the analysis of association studies","volume":"22","author":"Sole","year":"2006","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.cyto.2019.154781_b0215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.a.36887","article-title":"Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1","volume":"Part A 167A","author":"Crow","year":"2015","journal-title":"American J. Med. Genet."},{"issue":"9","key":"10.1016\/j.cyto.2019.154781_b0220","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ng2091","article-title":"Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus","volume":"39","author":"Lee-Kirsch","year":"2007","journal-title":"Nature Genet."},{"issue":"1","key":"10.1016\/j.cyto.2019.154781_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/reumatismo.2015.782","article-title":"Typing TREX1 gene in patients with systemic lupus erythematosus","volume":"67","author":"Fredi","year":"2015","journal-title":"Reumatismo"},{"issue":"4","key":"10.1016\/j.cyto.2019.154781_b0230","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"issue":"7659","key":"10.1016\/j.cyto.2019.154781_b0235","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature22821","article-title":"Microglia-dependent synapse loss in type I interferon-mediated lupus","volume":"546","author":"Bialas","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cyto.2019.154781_b0240","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/QAD.0b013e328354b3c2","article-title":"Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection","volume":"26","author":"Sironi","year":"2012","journal-title":"Aids"},{"issue":"1","key":"10.1016\/j.cyto.2019.154781_b0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12864-017-3609-6","article-title":"Bicodon bias can determine the role of synonymous SNPs in human diseases","volume":"18","author":"McCarthy","year":"2017","journal-title":"BMC Genomics"},{"issue":"3","key":"10.1016\/j.cyto.2019.154781_b0250","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/clim.2000.4866","article-title":"Induction of Fas ligand-mediated apoptosis by interferon-alpha","volume":"95","author":"Kirou","year":"2000","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2019.154781_b0255","first-page":"1689","article-title":"Inhibition of neuroblastoma cell growth by TREX1-mutated human lymphocytes","volume":"27","author":"Pulliero","year":"2012","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.cyto.2019.154781_b0260","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheumat."},{"key":"10.1016\/j.cyto.2019.154781_b0265","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.genet.38.072902.092448","article-title":"Repair and genetic consequences of endogenous DNA base damage in mammalian cells","volume":"38","author":"Barnes","year":"2004","journal-title":"Ann. Rev Genet."},{"issue":"2","key":"10.1016\/j.cyto.2019.154781_b0270","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mc.22921","article-title":"Characterization of DNA double-strand break repair pathways in diffuse large B cell lymphoma","volume":"58","author":"Gopalakrishnan","year":"2019","journal-title":"Mol. Carcinogenesis"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619302108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619302108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:56:38Z","timestamp":1760907398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466619302108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":54,"alternative-id":["S1043466619302108"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2019.154781","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TREX1 variants in Sjogren's syndrome related lymphomagenesis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2019.154781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"154781"}}